| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 2.22e-05 | 108 | 108 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 3.17e-05 | 115 | 108 | 6 | GO:0150115 | |
| MousePheno | lung hemorrhage | 1.92e-05 | 52 | 89 | 5 | MP:0001182 | |
| Domain | HECT | 1.67e-05 | 27 | 108 | 4 | PF00632 | |
| Domain | HECTc | 1.67e-05 | 27 | 108 | 4 | SM00119 | |
| Domain | HECT_dom | 1.67e-05 | 27 | 108 | 4 | IPR000569 | |
| Domain | HECT | 1.67e-05 | 27 | 108 | 4 | PS50237 | |
| Domain | Abi_HHR | 9.90e-05 | 3 | 108 | 2 | PF07815 | |
| Domain | Abl-interactor_HHR_dom | 9.90e-05 | 3 | 108 | 2 | IPR012849 | |
| Domain | Mib_Herc2 | 1.97e-04 | 4 | 108 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 1.97e-04 | 4 | 108 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 1.97e-04 | 4 | 108 | 2 | PF06701 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | BICD2 SFXN4 ERP44 RBM45 DYNC2H1 PSMD7 MRPL45 CBR3 USP44 PPP2R1B UBXN2B BRCA1 HERC2 HECTD1 TARBP1 | 7.56e-07 | 1005 | 111 | 15 | 19615732 |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.39e-06 | 26 | 111 | 4 | 26949039 | |
| Pubmed | ABI1 WDR7 SMURF1 DHX57 FAM98A AP3B1 GRM5 PGM1 ITPR2 STK4 HPCA KCNA1 DST THY1 LMO7 PRKAR2A ARHGAP21 | 2.96e-06 | 1431 | 111 | 17 | 37142655 | |
| Pubmed | IPO8 DYNC2H1 ATG2B PSMD7 FASTKD2 STK4 TRAP1 SMARCA1 CPSF1 HERC2 ARHGAP21 | 4.03e-06 | 606 | 111 | 11 | 36538041 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.10e-06 | 202 | 111 | 7 | 33005030 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 17996703 | ||
| Pubmed | 6.09e-06 | 513 | 111 | 10 | 25798074 | ||
| Pubmed | 9.04e-06 | 228 | 111 | 7 | 30471916 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 31006587 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26918600 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 16401422 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 11516653 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.12e-05 | 329 | 111 | 8 | 34316702 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M KRT13 SYNM LAD1 ITGB4 ITPR2 MYOF THBS1 DST LMO7 SMARCA1 SLTM CPSF1 UTP20 GNAI2 | 1.14e-05 | 1257 | 111 | 15 | 36526897 |
| Pubmed | Regulation of cell-cell adhesion by Abi/Diaphanous complexes. | 3.02e-05 | 3 | 111 | 2 | 19158278 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 19717561 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 27759030 | ||
| Pubmed | In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review). | 3.02e-05 | 3 | 111 | 2 | 12011975 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 21157449 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 27513329 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 38569496 | ||
| Pubmed | TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. | 3.02e-05 | 3 | 111 | 2 | 25480944 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22431752 | ||
| Pubmed | TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation. | 3.02e-05 | 3 | 111 | 2 | 33065966 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 20631078 | ||
| Pubmed | ARHGEF28 ERP44 SYNM DYNC2H1 PWWP2A MYOF TTBK1 RASGRP3 HECTD1 | 3.02e-05 | 493 | 111 | 9 | 15368895 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | IPO8 ERP44 FAM98A AP3B1 STK4 LMO7 IGHMBP2 PRKAR2A UTP20 HERC2 HECTD1 | 3.07e-05 | 754 | 111 | 11 | 33060197 |
| Pubmed | 4.24e-05 | 515 | 111 | 9 | 31617661 | ||
| Pubmed | 4.66e-05 | 22 | 111 | 3 | 30089695 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 LAD1 ITGB4 GADD45A ITPR2 MYOF DST CPSF1 LRP5 HERC2 CABIN1 HECTD1 ARHGAP21 | 5.29e-05 | 1105 | 111 | 13 | 35748872 |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 21224474 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 15143189 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 15650754 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 10995551 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 26022109 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 19403692 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 15371459 | ||
| Pubmed | Characterization of the antiplasmin activity of human thrombospondin-1 in solution. | 6.03e-05 | 4 | 111 | 2 | 7679575 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 7775583 | ||
| Pubmed | Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. | 6.03e-05 | 4 | 111 | 2 | 14668477 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 37890777 | ||
| Pubmed | The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy. | 6.03e-05 | 4 | 111 | 2 | 37481723 | |
| Pubmed | NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. | 6.03e-05 | 4 | 111 | 2 | 25692647 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 34253615 | ||
| Pubmed | Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. | 6.03e-05 | 4 | 111 | 2 | 19421330 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 20173781 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 20026598 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 11375975 | ||
| Pubmed | 6.91e-05 | 25 | 111 | 3 | 23271346 | ||
| Pubmed | 8.10e-05 | 71 | 111 | 4 | 16829211 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BICD2 IPO8 HAUS5 CPS1 STK4 PPP2R1B THBS1 TRAP1 PRKAR2A GNAI2 GNAT1 HERC2 PTTG2 | 8.27e-05 | 1155 | 111 | 13 | 20360068 |
| Pubmed | ABI1 DHX57 FAM98A AP3B1 PWWP2A MYOF TMEM120A DST BRCA1 ABI2 IGHMBP2 PRKAR2A UTP20 HERC2 C8orf33 | 8.43e-05 | 1497 | 111 | 15 | 31527615 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 28658604 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 34245686 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 28425671 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 22814251 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 10903848 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 23071553 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 15572692 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 21173240 | ||
| Pubmed | Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. | 1.00e-04 | 5 | 111 | 2 | 28287406 | |
| Pubmed | Inhibition of HECT E3 ligases as potential therapy for COVID-19. | 1.00e-04 | 5 | 111 | 2 | 33762578 | |
| Pubmed | Structure and function of hemidesmosomes: more than simple adhesion complexes. | 1.00e-04 | 5 | 111 | 2 | 10201522 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RASA2 DHX57 PSMD7 FASTKD2 FAM98A STK4 POLR1D DST SMARCA1 SLTM CPSF1 UTP20 GNAI2 HERC2 | 1.06e-04 | 1353 | 111 | 14 | 29467282 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 ERP44 ITGB4 ITPR2 MYOF THBS1 THY1 CPSF1 LRP5 UTP20 GNAI2 HECTD1 ARHGAP21 | 1.22e-04 | 1201 | 111 | 13 | 35696571 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | A2M KRT13 DHX57 PSMD7 FAM98A ITGB4 ITPR2 USP44 TRAP1 ARHGAP21 | 1.23e-04 | 732 | 111 | 10 | 34732716 |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 15252135 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 27470516 | ||
| Pubmed | A Smad action turnover switch operated by WW domain readers of a phosphoserine code. | 1.50e-04 | 6 | 111 | 2 | 21685363 | |
| Pubmed | BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. | 1.50e-04 | 6 | 111 | 2 | 11777930 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 25078664 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 30560934 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 10358086 | ||
| Pubmed | A2M IPO8 WDR7 DYNC2H1 FAM98A MYOF CPSF1 GNAI2 GRIP2 ARHGAP21 | 1.56e-04 | 754 | 111 | 10 | 35906200 | |
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 1.61e-04 | 33 | 111 | 3 | 15755804 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.01e-04 | 497 | 111 | 8 | 36774506 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.02e-04 | 262 | 111 | 6 | 36880596 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 35108541 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 30587574 | ||
| Pubmed | Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization. | 2.10e-04 | 7 | 111 | 2 | 14592966 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 10964520 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 20301312 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 10637308 | ||
| Pubmed | The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. | 2.10e-04 | 7 | 111 | 2 | 19056682 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.21e-04 | 92 | 111 | 4 | 15840729 | |
| Pubmed | 2.31e-04 | 645 | 111 | 9 | 25281560 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 2.50e-04 | 95 | 111 | 4 | 29643511 | |
| Pubmed | ABI1 WDR7 GRM5 NEDD4 KCNA1 DST ABI2 PRKAR2A HERC2 CABIN1 ARHGAP21 | 2.64e-04 | 963 | 111 | 11 | 28671696 | |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 2.67e-04 | 177 | 111 | 5 | 22560297 | |
| Pubmed | High-resolution linkage map in the proximity of the host resistance locus Cmv1. | 2.79e-04 | 8 | 111 | 2 | 9027502 | |
| Pubmed | HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. | 2.79e-04 | 8 | 111 | 2 | 17140287 | |
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 21107423 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 11950062 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 17903303 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SFXN4 IPO8 SYNM ATG2B DHX57 PSMD7 FASTKD2 MRPL45 ITPR2 TRAP1 DST CPSF1 PRKAR2A HERC2 | 2.97e-04 | 1496 | 111 | 14 | 32877691 |
| Pubmed | 3.53e-04 | 104 | 111 | 4 | 9205841 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 23727513 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 23901102 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 9192769 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 12482924 | ||
| Interaction | TNIK interactions | BICD2 ABI1 SMURF1 GRM5 NEDD4 DST ABI2 PRKAR2A HERC2 CABIN1 ARHGAP21 | 6.99e-06 | 381 | 109 | 11 | int:TNIK |
| Cytoband | 4p12 | 1.07e-03 | 20 | 111 | 2 | 4p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 1.59e-03 | 205 | 111 | 4 | chr2q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p11 | 1.81e-03 | 26 | 111 | 2 | chr3p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 2.10e-03 | 104 | 111 | 3 | chr2p22 | |
| Cytoband | 2q33 | 2.25e-03 | 29 | 111 | 2 | 2q33 | |
| Cytoband | 2q33.3 | 2.41e-03 | 30 | 111 | 2 | 2q33.3 | |
| GeneFamily | PDZ domain containing | 3.50e-04 | 152 | 72 | 5 | 1220 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 2.59e-06 | 144 | 110 | 7 | M335 | |
| Coexpression | DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS | 1.63e-05 | 127 | 110 | 6 | M40138 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 2.08e-05 | 198 | 110 | 7 | M8274 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | KRT13 DYNC2H1 ECHDC1 MRPL45 AP3B1 USP44 STK4 HPCA BRCA1 SLTM PRKAR2A DNAI4 UTP20 HECTD1 ARHGAP21 EPHA3 | 2.76e-05 | 989 | 105 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 4.81e-05 | 80 | 105 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 6.16e-05 | 137 | 105 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#1_top-relative-expression-ranked_200 | 6.81e-05 | 86 | 105 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 6.81e-05 | 86 | 105 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 7.69e-05 | 361 | 105 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_100 | 7.85e-05 | 46 | 105 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.13e-04 | 153 | 105 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.25e-04 | 385 | 105 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 1.31e-04 | 157 | 105 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 1.38e-04 | 390 | 105 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 1.66e-04 | 164 | 105 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_1000 | CIDEB PECR SATB2 ECHDC1 GADD45A MYOF THY1 LMO7 RASGRP3 SMARCA1 ITM2A EPHA3 NPNT | 1.89e-04 | 814 | 105 | 13 | gudmap_kidney_e15.5_Podocyte_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 2.19e-04 | 415 | 105 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SFXN4 DYNC2H1 ECHDC1 DHX57 AP3B1 STK4 HPCA BRCA1 SLTM DNAI4 HECTD1 ARHGAP21 EPHA3 | 2.31e-04 | 831 | 105 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.78e-09 | 200 | 110 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.68e-08 | 200 | 110 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-07 | 196 | 110 | 7 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-07 | 196 | 110 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.03e-07 | 197 | 110 | 7 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 3.24e-06 | 163 | 110 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 179 | 110 | 6 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-06 | 182 | 110 | 6 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-06 | 186 | 110 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-06 | 193 | 110 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-06 | 193 | 110 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-06 | 193 | 110 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 110 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 195 | 110 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-06 | 195 | 110 | 6 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.31e-06 | 196 | 110 | 6 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.31e-06 | 196 | 110 | 6 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.31e-06 | 196 | 110 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.31e-06 | 196 | 110 | 6 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.31e-06 | 196 | 110 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.58e-06 | 197 | 110 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.58e-06 | 197 | 110 | 6 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.58e-06 | 197 | 110 | 6 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.58e-06 | 197 | 110 | 6 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.86e-06 | 198 | 110 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.86e-06 | 198 | 110 | 6 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.86e-06 | 198 | 110 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 199 | 110 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.01e-05 | 199 | 110 | 6 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.01e-05 | 199 | 110 | 6 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 199 | 110 | 6 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-05 | 200 | 110 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.04e-05 | 200 | 110 | 6 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-05 | 200 | 110 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 200 | 110 | 6 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 200 | 110 | 6 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 57 | 110 | 4 | ade0457d85acaf87fcbeb6ac0d81525bb4a96950 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 57 | 110 | 4 | 0e92c8af66bfdf9de6410c82f404b65b1424e09c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 57 | 110 | 4 | 00083b7c710affa6e24ed495ed46ec6fcea8b676 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.13e-05 | 146 | 110 | 5 | df865558d1843f3857ebd1529cebc540d3554c59 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 4.42e-05 | 157 | 110 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 158 | 110 | 5 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.70e-05 | 159 | 110 | 5 | a710551512aa0b7a281a81bea651a43c9f3b3539 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 160 | 110 | 5 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 160 | 110 | 5 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.10e-05 | 168 | 110 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-05 | 169 | 110 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.63e-05 | 171 | 110 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.63e-05 | 171 | 110 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.82e-05 | 172 | 110 | 5 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-05 | 173 | 110 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 7.20e-05 | 174 | 110 | 5 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.20e-05 | 174 | 110 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 7.20e-05 | 174 | 110 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.40e-05 | 175 | 110 | 5 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-05 | 175 | 110 | 5 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 7.60e-05 | 176 | 110 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 7.60e-05 | 176 | 110 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 176 | 110 | 5 | 135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.60e-05 | 176 | 110 | 5 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-05 | 176 | 110 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 176 | 110 | 5 | 2287bd8382f41e36ebb0875a0133bada1ec81fa7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 177 | 110 | 5 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.02e-05 | 178 | 110 | 5 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.02e-05 | 178 | 110 | 5 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 178 | 110 | 5 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 178 | 110 | 5 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 178 | 110 | 5 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal-Cortical_neuron|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 8.05e-05 | 34 | 110 | 3 | 6c9c477b43009cded5a2e1a1792c32c40d9309a8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.23e-05 | 179 | 110 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 8.45e-05 | 180 | 110 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-05 | 180 | 110 | 5 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.67e-05 | 181 | 110 | 5 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.67e-05 | 181 | 110 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 8.67e-05 | 181 | 110 | 5 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.67e-05 | 181 | 110 | 5 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.67e-05 | 181 | 110 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-05 | 182 | 110 | 5 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.13e-05 | 183 | 110 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.13e-05 | 183 | 110 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 9.13e-05 | 183 | 110 | 5 | f10e72a2e2e6cdc1984f469a60244e5fd8a10095 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.13e-05 | 183 | 110 | 5 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.13e-05 | 183 | 110 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.37e-05 | 184 | 110 | 5 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 9.37e-05 | 184 | 110 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.37e-05 | 184 | 110 | 5 | 219bd3b8daa0a713fb6a8a5e1bb35cdb85bb7727 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.61e-05 | 185 | 110 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.61e-05 | 185 | 110 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.86e-05 | 186 | 110 | 5 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 187 | 110 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.74e-07 | 196 | 110 | 9 | 2829_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 3.72e-06 | 188 | 110 | 8 | 7091_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 4.87e-06 | 195 | 110 | 8 | 834_UP | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; HL60; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 2149_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 3940_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.45e-06 | 198 | 110 | 8 | 1826_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A | 5.66e-06 | 199 | 110 | 8 | 365_DN | |
| Drug | AC1L9INI | 9.77e-06 | 59 | 110 | 5 | CID000445839 | |
| Drug | DL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 4.59e-05 | 195 | 110 | 7 | 1121_DN | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 5071_DN | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 5759_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 3098_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 1635_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; HL60; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 2140_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 5996_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 7381_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 4133_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 4637_DN | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 5.22e-05 | 199 | 110 | 7 | 366_DN | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 1490_DN | |
| Drug | D-glucamine | 6.60e-05 | 45 | 110 | 4 | CID000027282 | |
| Disease | Plasmodium falciparum antigen IgG measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0007812 | |
| Disease | Epidermolysis Bullosa Simplex | 1.22e-04 | 5 | 104 | 2 | C0079298 | |
| Disease | osteonecrosis (biomarker_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:10159 (biomarker_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 3.40e-04 | 8 | 104 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800074 | |
| Disease | ximenoylcarnitine (C26:1) measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0800543 | |
| Disease | response to opioid | 1.32e-03 | 61 | 104 | 3 | EFO_0008541 | |
| Disease | omega-3 polyunsaturated fatty acid measurement, diet measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0008111, EFO_0010119 | |
| Disease | Malignant neoplasm of breast | ABCA3 DYNC2H1 POLH CNTN6 NEDD4 THBS1 BRCA1 UTP20 GNAI2 HERC2 GABRA4 | 1.44e-03 | 1074 | 104 | 11 | C0006142 |
| Disease | Cleft Palate | 2.97e-03 | 81 | 104 | 3 | C0008925 | |
| Disease | Drug-Induced Liver Disease | 3.12e-03 | 404 | 104 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 3.12e-03 | 404 | 104 | 6 | C3658290 | |
| Disease | Hepatitis, Toxic | 3.12e-03 | 404 | 104 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 3.12e-03 | 404 | 104 | 6 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 3.12e-03 | 404 | 104 | 6 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 3.12e-03 | 404 | 104 | 6 | C1262760 | |
| Disease | cleft lip | 3.38e-03 | 284 | 104 | 5 | EFO_0003959 | |
| Disease | FEV change measurement, response to zileuton | 3.50e-03 | 25 | 104 | 2 | EFO_0005921, EFO_0007676 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSRGVDNSKISVLIL | 81 | Q6ZS49 | |
| KLSTIALALGVERTR | 46 | P30154 | |
| RNEIKNGTILRLTTS | 66 | Q92556 | |
| TRGSLSEQQEKVTRL | 376 | Q8TD16 | |
| SLLSTKREQITTLRT | 681 | Q8TD16 | |
| EQAIGAIRTLRSKRT | 136 | Q9H7E9 | |
| DITKAALGVLRQSRV | 206 | P22570 | |
| TVARARESGKAIIIT | 1556 | Q99758 | |
| TLEITKRLVGAISRA | 2471 | Q86UQ4 | |
| RREIGILTTNKNTSR | 106 | Q8IZP0 | |
| GELLQRLRDISTVKS | 141 | P20800 | |
| TLLRRFGSQLIKSTV | 291 | Q4L235 | |
| RIVIRIQRGKSTSSS | 31 | Q96K78 | |
| NSKTGTALEIRIERT | 181 | Q96BY7 | |
| RREIGILTTNKNTSR | 106 | Q9NYB9 | |
| TGRQSSEITRTITKL | 336 | P01023 | |
| EAGIISKSLVRLLRS | 331 | O00203 | |
| SIALKVSQLQERTGR | 541 | P36871 | |
| RGQEAISKRLSVVSR | 241 | Q8IUH3 | |
| RTLTLISKTIQTLGS | 536 | Q15283 | |
| IIALSVTSRGRLEQK | 86 | P84074 | |
| LLNVIKSVTRNGRSI | 2381 | Q14571 | |
| KSVTRNGRSIILTAV | 2386 | Q14571 | |
| LGKTRLVRELTVCSS | 566 | Q8N1W1 | |
| PVTSLLTSGRRKTID | 5956 | Q8WXI7 | |
| RKENLRLSGVVTSRL | 461 | O00515 | |
| KGEQATSLAILRVIR | 281 | Q09470 | |
| ALVTKTNRIARILAG | 661 | P41594 | |
| SEKRIRLLQFVTGTS | 1236 | P46934 | |
| RQTQITLRGADIKSV | 521 | Q6UXI9 | |
| LRSRVKTTGIIETQF | 171 | P11488 | |
| TTRLVEIIGSRQALK | 196 | Q9NTX5 | |
| QRLRKLLTTEFGQSI | 3776 | O95714 | |
| KLQITLTRSLSVQDG | 4151 | Q03001 | |
| GQSLTKIETLRLAIR | 116 | Q0VG99 | |
| EVTRLNGTSRKILVS | 441 | O75197 | |
| TSKTEITELRRTLQG | 316 | P13646 | |
| VKEVLLVALGSRQSR | 846 | Q10570 | |
| ATRTVRLQLLSKETG | 611 | P51805 | |
| TGIKSEFRSVLSIRQ | 196 | P53370 | |
| RSGLFVLTVRTKLVS | 661 | O15018 | |
| LGSNVVIASRKLERL | 41 | Q9BY49 | |
| ILRTEQNSGRTILIK | 61 | Q8WWI1 | |
| SRLQRIKTTVNTIGA | 481 | P48169 | |
| VGVLVSQRSTLLKER | 301 | O94927 | |
| ITSVLRISSSQGRLK | 221 | P0C7N8 | |
| QGRLTRVLLTASTLK | 211 | Q15466 | |
| TATLGRRLVNITIIK | 971 | P16144 | |
| LETISTATGRKLLVS | 326 | O76062 | |
| LSNLGTVRTLRTKQR | 156 | P38398 | |
| IRGTTLLSSEVQKLA | 4101 | Q8NCM8 | |
| SSIRKLIRDGSIDLV | 1421 | P31327 | |
| RLALTLKVTGLGTTR | 1816 | Q9ULT8 | |
| ILKVSSSTTGLVRLT | 806 | Q9Y6J0 | |
| VLSKALSQRTITVGV | 26 | P24522 | |
| RGSRIISTIVKLVTT | 1371 | Q6P158 | |
| GTETLRQSKRIFLLE | 446 | Q9UQ52 | |
| ILRARGTNVTISSLK | 486 | P29320 | |
| REFVAILKNLTTTGR | 356 | Q5I0G3 | |
| ILRQLTKTSRELDGI | 41 | Q86TE4 | |
| IISGSLSIATEKRLT | 96 | Q9H2W1 | |
| SRTVRTQILTGKELR | 26 | O43736 | |
| AEITTLDRSKRNIIG | 151 | Q9BS26 | |
| VSKLGVTVLSRILAR | 196 | O75828 | |
| REILVSISADGRISK | 606 | Q5VTH9 | |
| GRRRLVGKETSINTL | 321 | Q9NWQ4 | |
| IESGEVSILIRSRTK | 301 | P13861 | |
| TISSASRKRGEPLII | 571 | Q9C0E4 | |
| TARIRAVGLLTVISK | 41 | O43653 | |
| ISQLKTLDLSGIRLT | 226 | H0Y7S4 | |
| SIDKLSLLVSGRIRV | 151 | Q9HBV1 | |
| SARERVTLSKGVAVL | 261 | A6NL08 | |
| LERLTRGVKTSELRT | 766 | O15397 | |
| SESKINLRIQTRGTL | 76 | P0DPB6 | |
| SKRITLIEGARVTLT | 1431 | P0C091 | |
| ANISTGVSKIRLLTI | 636 | O75691 | |
| ARILTITVSRKDNGL | 671 | Q96N64 | |
| IVREFKSTNRLLLTG | 326 | P28370 | |
| AGTKAVRETLASRIV | 241 | Q6P4A7 | |
| STRSNERTVILGKKT | 486 | O15061 | |
| TIRESILINNGSRIK | 176 | Q9BXJ8 | |
| RISSLSKEGLIERTE | 96 | Q9BRJ2 | |
| LRDIKDTTVGTLSQR | 176 | P51665 | |
| LSLTSGDVTKRLLIQ | 91 | Q8NCA5 | |
| QTKGISTLTALRIER | 91 | Q9NYY8 | |
| TQQDVLRTRVKTTGI | 171 | P04899 | |
| ITLVTGSSRKISVRL | 591 | Q8IV61 | |
| RRNLDITGVKTVLIS | 36 | Q9NWH9 | |
| RSRTKISLEALGILQ | 616 | Q9UPW6 | |
| KRRLATLTGLSLTQV | 231 | Q8N196 | |
| SIKALDGISQVLTRR | 31 | Q9NZH5 | |
| LVVSIRVQGDKRLSS | 366 | Q9Y253 | |
| VLGSQKLTQLRDSIR | 206 | Q92966 | |
| TRRNGSSIKIRLTVL | 6 | Q9HCE7 | |
| TIRKGLTAATRQELL | 46 | Q9UHD4 | |
| GLRTIVTTLQDSIRK | 286 | P07996 | |
| FTLSTTLRLGKQILE | 126 | Q5TCY1 | |
| TTKIQIRLADGSRLI | 256 | Q14CS0 | |
| SSKIIQISSGRELRV | 256 | Q9UMS6 | |
| LATGILTRVTQKSVT | 101 | P38935 | |
| CLTSKGRELTRISLV | 236 | Q96IC2 | |
| GTRTLTRVKVQDLVL | 91 | Q8N3Z0 | |
| LEIRTSKRTELAQGQ | 186 | Q9NS62 | |
| KIDTNRIRTENGSIL | 996 | Q8IZM8 | |
| RKSGTLSVLQCRLIE | 796 | Q6P2S7 | |
| LTVLQVSRGQKVTSL | 11 | P04216 | |
| GSRVTNVKVTLRLDT | 591 | Q12931 | |
| VRSAKGVSILRDLIN | 281 | Q13043 | |
| RLGKSISRLIVVASL | 1456 | Q13395 | |
| TGVTNRDLISRRIKE | 1046 | Q5T5U3 | |
| TTTLARAKGEILRVI | 1296 | Q9Y4E6 | |
| EAIRGQILSKLRLTS | 41 | P10600 | |
| RKSLRLQGLAQSTII | 211 | Q9H0E7 | |
| GTVSEAQLARRLTKV | 171 | Q9NZM1 |